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relative risk reduction that we found was similar to those
published on the basis of results from RCTs.
CN7
REDUCING ANTICHOLINERGIC 
ANTIDEPRESSANT USE IN THE ELDERLY: 
A RANDOMIZED TRIAL OF GROUP VERSUS 
INDIVIDUAL “ACADEMIC DETAILING”
Van Eijk MEC1,2, Avorn J3, Porsius AJ1, de Boer A1
1Utrecht Institute of Pharmaceutical Sciences, Utrecht, 
The Netherlands; 2Health Insurance Company 
“OZ-zorgverzekeringen”, Breda, The Netherlands; 3Division of 
Pharmacoepidemiology, Department of Medicine, Brigham and 
Women’s Hospital, Harvard Medical School, Boston, MA, USA
OBJECTIVES: Dissemination of medical knowledge and
implementation of knowledge needs to be better under-
stood. Academic detailing can effectively change prescrib-
ing, but it is very resource demanding. This research com-
pares the effect of an educational intervention through
individual outreach visits and through a group approach,
using academic detailing.
METHODS: We conducted a randomized controlled trial
to measure the effect of two educational programs on pre-
scribing (individual intervention arm and group interven-
tion arm versus control arm) to reduce anticholinergic anti-
depressant (AAD) prescribing for the elderly. We included
all General Practitioners (GPs) and pharmacists (approx.
230) in the southwest Netherlands health district and used a
database covering all prescriptions to persons insured by the
national health insurance system in this area (approx.
240,000).
RESULTS: In the individual arm 43 of 70 GPs were visited;
in the group arm 5 of 7 groups (41 of 52 GPs) agreed to join
the program. Using an intention to treat analyses there was
a reduction in the incidence of AAD in elderly of 26% (95%
confidence interval 4%–48%) in the individual arm and
of 45% (8%–67%) in the group arm. The use of non-AAD
in the elderly increased by 40% (6%–83%) in the individual
arm and by 29% (7%–79%) in the group arm.
CONCLUSIONS: Both the individual and the group ap-
proach significantly decreased the incidence of AAD and in-
creased the incidence of non-AAD use in the elderly. These
approaches are practical means of improving the clinical ap-
propriateness of medication use on a large scale among pri-
mary care physicians.
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Dissention exists among health economists regarding the
measurement and inclusion of productivity costs in a cost-
utility analysis. Some health economists believe that produc-
tivity costs are captured by quality-adjusted life years
(QALYs) in the denominator of the cost-utility ratio. Others
argue that productivity costs should be measured mone-
tarily via the friction cost method or the human capital
method, and included in the numerator of the ratio.
OBJECTIVES: (1) To investigate the extent to which
changes in productivity costs are explained by changes in
QALYs. (2) To examine the difference between the hu-
man capital method and the friction cost method.
METHODS: An observational panel study with two sur-
vey waves was used to collect data. Surveys were admin-
istered through face-to-face interviews to a convenience
sample of 102 informal caregivers of the elderly.
RESULTS: Changes in QALYs did not explain absence
from paid labor, reduced productivity during paid labor,
and lost leisure productivity costs. However, changes in
QALYs did account for ten percent of the variance in
changes in lost unpaid labor (F  8.67, P  0.01). Fric-
tion cost estimates were significantly less than human
capital estimates in both the first and second waves of the
study (t  6.96, P  0.01, t  6.47, P  0.01).
CONCLUSIONS: Most productivity cost components
should be valued monetarily, and included in the numer-
ator of a cost-utility ratio. If the friction cost method is
used, rather than the human capital method, smaller esti-
mates of productivity costs will be obtained.
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OBJECTIVES: To examine the likely cost savings to the
NHS of reclassification of a medicine from prescription
only medicine (POM) to pharmacy (P) status.
METHODS: We used the General Practice Research Data-
base to look at changes in GP prescriptions for acyclovir
cream 5% before and after reclassification. To control for
the effects of prescription charges we categorized the data
into three patient age groups: 0–19, 20–59 and 60.
RESULTS: There was a 49% reduction in prescribing
rate in the 20–59 age group which has no prescription
charge exemptions on age grounds. For an average sized
general practice about 65 consultations would be saved
annually. Annual savings to the National Health Service
due to reclassification of one product are calculated to be
more than £5 million.
